Business Context and Reporting Period
Company: Pacific Biosciences of California, Inc.
Filing Type: Form 8-K (Current Report)
Report Date: August 4, 2016
Reporting Period: Second fiscal quarter ended June 30, 2016
This filing serves as a notification that the company announced its financial results for the second quarter of 2016. The detailed results are contained in a press release (Exhibit 99.1) incorporated by reference.
Key Financial Metrics
The provided text is a cover document for the 8-K filing and does not contain specific numerical data. Consequently, the following metrics are not available in this source text:
- Revenue
- Profit/Loss
- Cash Flow
- Margins
- Debt and Liquidity
Note: The filing text does not provide a clear value for any financial metric; these figures are located in the referenced Exhibit 99.1.
Material Changes
The filing text does not disclose specific material changes versus the prior comparable period. It only confirms the announcement of the Q2 2016 results.
Guidance, Outlook, and Risks
The text does not include management commentary, forward-looking guidance, specific risks, or contingencies. It explicitly states that the press release (Exhibit 99.1) is furnished under Item 2.02 and is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 4, 2016) for actual revenue, net loss, and cash position figures.
- Verify the specific year-over-year and quarter-over-quarter performance metrics in the full press release.
- Check for any updated financial guidance or operational outlook provided in the press release.
- Confirm the status of the company's cash runway and burn rate as detailed in the full financial results.